Broker Recommendations |
||||||||||||||||
In a research note published this morning, the analysts mention that the company's growth prospects are being driven by a strong agchem pipeline, improving prices and an increase in GM (NYSE: GM - news) seeds. Syngenta is expected to deliver 14% CAGR EPS growth in 2010-2012, the analysts add. The EPS estimates for 2010-2012 have been raised by 3%-8%. © 2009 New Ratings
Click here for more articles from NewRatings.com
|
| |||||||||||||||